From Self-Organization to Tumor-Immune Therapy: How Things Started and How They Evolved
Macromol Rapid Commun
.
2022 Jun;43(12):e2100829.
doi: 10.1002/marc.202100829.
Authors
Matthias Barz
1
2
,
Lutz Nuhn
3
,
Gerhard Hörpel
4
,
Rudolf Zentel
5
Affiliations
1
Leiden Academic Center for Drug Research (LACDR), Einsteinweg 55, 2333 CC Leiden, The Netherlands.
2
Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.
3
Max Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.
4
GBH Gesellschaft für Batterie Know-how mbH, Lerchenhain 84, 48301, Nottuln, Germany.
5
Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128, Mainz, Germany.
PMID:
35729069
DOI:
10.1002/marc.202100829
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Neoplasms* / therapy
Grants and funding
213555243 (SFB 1066)/Deutsche Forschungsgemeinschaft